DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Cancidas (Caspofungin) - Hepatic Failure - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Hepatic Failure (6)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Cancidas (Caspofungin) where reactions include hepatic failure. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Hepatic Failure, Drug Interaction, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-26

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Respiratory Distress, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death, hospitalization

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciproflaxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-17

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vfend
    Administration route: Oral

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in female

Reported by a health professional (non-physician/pharmacist) from France on 2012-07-16

Patient: female

Reactions: Bronchopulmonary Aspergillosis, Hypersensitivity, Drug Interaction, Hepatic Failure, Generalised Oedema, Immunosuppressant Drug Level Decreased, Renal Impairment, Bone Marrow Failure, Multiple Drug Overdose, Renal Failure Acute

Adverse event resulted in: death

Drug(s) suspected as cause:
Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-23

Atgam
    Dosage: 40 mg/kg, unk
    Start date: 2012-04-25
    End date: 2012-04-27

Bactrim
    Dosage: 1 df, qw3
    Indication: Prophylaxis
    Start date: 2012-04-01

Cancidas
    Start date: 2012-05-28
    End date: 2012-05-30

Ciprofloxacin
    Start date: 2012-05-28
    End date: 2012-06-06

Clavulanate Potassium
    Dosage: unk
    Start date: 2012-06-04

Clavulanate Potassium
    Dosage: 1 df, tid
    Start date: 2012-05-28
    End date: 2012-06-01

Other drugs received by patient possibly interacting with the suspect drug:
Gentamicin

Neoral
    Dosage: 1 df, bid
    Administration route: Oral
    Start date: 2012-04-23

Vancomycin
    Dosage: 1800 mg, unk
    Start date: 2012-06-06

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-06-04

Vancomycin
    Dosage: 2000 mg, unk
    Start date: 2012-05-25

Vancomycin
    Dosage: 2250 mg, unk
    Start date: 2012-05-31

Vancomycin
    Dosage: 1 g, bid
    Start date: 2012-05-22

Vfend
    Dosage: 1 df, bid
    Indication: Bronchopulmonary Aspergillosis
    Start date: 2012-05-14
    End date: 2012-05-31

Vfend
    Administration route: Oral

Other drugs received by patient: Colistin; Neupogen



Possible Cancidas side effects in

Reported by a physician from Germany on 2012-04-17

Patient:

Reactions: Hepatic Failure

Drug(s) suspected as cause:
Cancidas



Possible Cancidas side effects in female

Reported by a physician from Germany on 2011-12-21

Patient: female

Reactions: Hepatic Failure

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cancidas

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017